|
| EDITORIAL COMMENTARY |
|
| Year : 2022 | Volume
: 68
| Issue : 2 | Page : 70-71 |
Tyrosine kinase domain mutations in chronic myelogenous leukemia patients: Indian perspective
K Ghosh
Fmr. Director, National Institute of Immunohaematology, KEM Hospital, Parel, Mumbai, Maharashtra, India
Correspondence Address:
K Ghosh
Fmr. Director, National Institute of Immunohaematology, KEM Hospital, Parel, Mumbai, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0022-3859.343150
[FULL TEXT] [PDF]*
|
